Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...

Self-mixing insulin requires a person to inject themselves with two types of insulin in one injection. A person can mix and inject insulin using a syringe. Insulin is a hormone that people use to ...

Credit: Getty Images. The recall does not pertain to the interchangeable biosimilars, Semglee (insulin glargine-yfgn) injection, or Insulin Glargine (insulin glargine-yfgn) injection. Mylan ...

The recalled product does not pertain to the branded interchangeable biosimilar, Semglee (insulin glargine-yfgn). Mylan Pharmaceuticals has voluntarily recalled 1 batch of Insulin Glargine (insulin ...